COPD Trial, Recruiting NCT06736145 Sponsor: Riphah International University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06736145
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with moderate (Grade II) or severe (Grade III) COPD (a lung condition that makes breathing difficult) for at least one year.
  • People whose COPD is currently stable and not in an active flare-up.

Who may not be able to join:

  • People who have any existing disease or condition affecting the neck area of the spine.
  • People who have any heart disease or heart condition.
  • People who have any other lung or breathing conditions alongside their COPD.
  • People who experience severe dizziness or severe coughing.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Asmar Fatima, MSOMPT, Riphah International University

Phone: 03336195644

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
30 April 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Tape Line; NPRS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov